GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Price-to-Operating-Cash-Flow

Q32 Bio (Q32 Bio) Price-to-Operating-Cash-Flow : (As of May. 15, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio Price-to-Operating-Cash-Flow?

As of today (2024-05-15), Q32 Bio's share price is $29.40. Q32 Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.12. Hence, Q32 Bio's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Q32 Bio's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 3 years, Q32 Bio's highest Price-to-Operating-Cash-Flow Ratio was 36.65. The lowest was 21.35. And the median was 28.18.

QTTB's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 26.61
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Q32 Bio's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-1.22. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.12.

Q32 Bio Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Q32 Bio's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio Price-to-Operating-Cash-Flow Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - -

Q32 Bio Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of Q32 Bio's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Q32 Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q32 Bio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Q32 Bio's Price-to-Operating-Cash-Flow falls into.


Q32 Bio Price-to-Operating-Cash-Flow Calculation

Q32 Bio's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=29.40/-2.118
=

Q32 Bio's Share Price of today is $29.40.
Q32 Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Q32 Bio Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Q32 Bio's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Q32 Bio (Q32 Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
Traded in Other Exchanges
N/A
Address
830 Winter Street, Waltham, MA, USA, 02451
Website
https://www.q32bio.com
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Q32 Bio (Q32 Bio) Headlines

From GuruFocus

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

By PRNewswire • 04-03-2024